Australia's largest stock trading and investment forum Australia's #1 stock forum

CAS

Click for more information

0.00%

0.0¢ crusader resources limited

Any issue 20% below VWAP should not be allowed by ASIC IMO, I...

First 8 Last

Share
Profile

Follow
McKhenry

726 Posts.

64

24/01/19

14:00

Post #: 37212490
Share

Originally posted by hotdog159: ↑

This is highly unusual.
Usually, a company short of cash will do a placement or rights issue, and say nothing about not otherwise being a going concern.
Those who bought 100k tickets in the convertible round did so having had deep discussions with management, and would not have bought without a sound funding plan.
So why bring up the 'not a going concern' now? This smells like last weeks fish.
Obviously a huge rights issue will follow at 0.5 cents or below, and we will be too scared to buy. That will leave the way clear for Coupolos, and the other insiders to get control on the cheap.
Then watch them sell down project ownership at a good price to develop the tenements. The first is meant to be largely funded, the second is in a hot area, and I was told by management last year that multiple funding options were being pursued.
We will know the fix is in, if they underwrite the rights. It makes me angry. I am sure this will happen, and we will get shafted.

Expand

Any issue 20% below VWAP should not be allowed by ASIC IMO, I believe you may have hit the nail on the head though

CAS Price at posting: 2.0¢ Sentiment: Sell Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

There are more pages in this discussion • 3 more messages in this thread...

First 8 Last

Add CAS (ASX) to my watchlist